Company Huaren Pharmaceutical Co., Ltd.

Equities

300110

CNE100000SW1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-05 pm EDT 5-day change 1st Jan Change
3.79 CNY +2.43% Intraday chart for Huaren Pharmaceutical Co., Ltd. +4.99% -10.19%

Business Summary

Huaren Pharmaceutical CO.,LTD is a China-based company principally engaged in the research, development, manufacture and distribution of non polyvinyl chloride (PVC) soft bag large volume preparations. The Company provides basic infusion products, including sodium chloride infusions, dextrose infusions and compound sodium chloride infusions, among others; infusion products for treatment, including metronidazole and sodium chloride infusions, ciprofloxacin lactate and sodium chloride infusions and others, as well as nutritious infusion products, among others. The Company distributes its products in domestic market, with Northeast China as its main market.

Number of employees: 2,264

Sales per Business

CNY in Million2021Weight2022Weight Delta
Basic Infusion
45.3 %
730 46.8 % 734 45.3 % +0.48%
Other
23.6 %
260 16.6 % 382 23.6 % +47.12%
Peritoneal Dialysis Fluid
17.0 %
233 14.9 % 276 17.0 % +18.54%
Therapeutic Preparation
11.4 %
122 7.8 % 185 11.4 % +51.04%
Pharmaceutical Raw Materials
2.7 %
216 13.9 % 44 2.7 % -79.83%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
100.0 %
1,561 100.0 % 1,619 100.0 % +3.76%

Managers

Managers TitleAgeSince
Chief Executive Officer 53 22-12-28
Director of Finance/CFO 39 20-10-25
Chairman 56 19-07-18
Investor Relations Contact - -
Corporate Secretary 44 16-12-22

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 19-08-27
Director/Board Member 67 19-08-27
Chairman 63 19-08-05
Director/Board Member 44 19-08-05
Chairman 56 19-07-18
Director/Board Member 39 22-04-20
Director/Board Member 50 22-04-20
Director/Board Member 49 19-08-05
Director/Board Member 69 22-01-10
Director/Board Member 53 22-04-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,182,212,982 433,267,388 ( 36.65 %) 0 36.65 %

Shareholders

NameEquities%Valuation
1,120,000 0.1143 % 554 770 ¥
Wanjia Asset Management Co., Ltd.
0.0712 %
697,400 0.0712 % 345 443 ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
0.0240 %
235,500 0.0240 % 116 650 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.0232 %
226,800 0.0232 % 112 341 ¥
Taikang Asset Management Co. Ltd.
0.0123 %
120,200 0.0123 % 59 539 ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
0.007636 %
74,800 0.007636 % 37 051 ¥
Lion Fund Management Co., Ltd.
0.000909 %
8,900 0.000909 % 4 408 ¥

Company contact information

Huaren Pharmaceutical Co., Ltd.

187 Zhuzhou Road Hi-tech Industrial Park

266101, Qingdao

+

http://www.qdhuaren.com
address Huaren Pharmaceutical Co., Ltd.(300110)
  1. Stock Market
  2. Equities
  3. 300110 Stock
  4. Company Huaren Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW